Annual Current Liabilities
$15.68 M
+$2.66 M+20.47%
31 December 2023
Summary:
Galectin Therapeutics annual total current liabilities is currently $15.68 million, with the most recent change of +$2.66 million (+20.47%) on 31 December 2023. During the last 3 years, it has risen by +$10.28 million (+190.35%). GALT annual current liabilities is now at all-time high.GALT Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$25.26 M
+$10.64 M+72.80%
30 September 2024
Summary:
Galectin Therapeutics quarterly total current liabilities is currently $25.26 million, with the most recent change of +$10.64 million (+72.80%) on 30 September 2024. Over the past year, it has increased by +$14.74 million (+140.05%). GALT quarterly current liabilities is now at all-time high.GALT Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GALT Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +20.5% | +140.1% |
| 3 y3 years | +190.3% | +204.3% |
| 5 y5 years | +643.6% | +1977.1% |
GALT Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +190.3% | at high | +204.3% |
| 5 y | 5 years | at high | +643.6% | at high | +1977.1% |
| alltime | all time | at high | +4047.1% | at high | +7990.3% |
Galectin Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $25.26 M(+72.8%) |
| June 2024 | - | $14.62 M(+15.7%) |
| Mar 2024 | - | $12.63 M(-19.4%) |
| Dec 2023 | $15.68 M(+20.5%) | $15.68 M(+49.0%) |
| Sept 2023 | - | $10.52 M(+5.7%) |
| June 2023 | - | $9.95 M(-13.7%) |
| Mar 2023 | - | $11.53 M(-11.4%) |
| Dec 2022 | $13.01 M(+44.0%) | $13.01 M(+35.7%) |
| Sept 2022 | - | $9.59 M(-12.0%) |
| June 2022 | - | $10.89 M(+14.2%) |
| Mar 2022 | - | $9.54 M(+5.6%) |
| Dec 2021 | $9.03 M(+67.3%) | $9.03 M(+8.8%) |
| Sept 2021 | - | $8.30 M(+37.1%) |
| June 2021 | - | $6.05 M(+29.8%) |
| Mar 2021 | - | $4.66 M(-13.6%) |
| Dec 2020 | $5.40 M(+91.5%) | $5.40 M(+117.0%) |
| Sept 2020 | - | $2.49 M(-41.8%) |
| June 2020 | - | $4.28 M(+224.8%) |
| Mar 2020 | - | $1.32 M(-53.3%) |
| Dec 2019 | $2.82 M(+33.8%) | $2.82 M(+131.9%) |
| Sept 2019 | - | $1.22 M(-7.8%) |
| June 2019 | - | $1.32 M(+45.4%) |
| Mar 2019 | - | $907.00 K(-57.0%) |
| Dec 2018 | $2.11 M(-29.0%) | $2.11 M(+28.1%) |
| Sept 2018 | - | $1.65 M(+14.7%) |
| June 2018 | - | $1.44 M(-37.1%) |
| Mar 2018 | - | $2.28 M(-23.1%) |
| Dec 2017 | $2.97 M(-21.5%) | $2.97 M(-31.6%) |
| Sept 2017 | - | $4.34 M(+23.6%) |
| June 2017 | - | $3.51 M(-19.5%) |
| Mar 2017 | - | $4.36 M(+15.4%) |
| Dec 2016 | $3.78 M(+177.9%) | $3.78 M(-7.5%) |
| Sept 2016 | - | $4.09 M(+12.4%) |
| June 2016 | - | $3.64 M(+11.9%) |
| Mar 2016 | - | $3.25 M(+139.0%) |
| Dec 2015 | $1.36 M(-20.1%) | $1.36 M(-21.2%) |
| Sept 2015 | - | $1.73 M(-9.5%) |
| June 2015 | - | $1.91 M(+47.8%) |
| Mar 2015 | - | $1.29 M(-24.2%) |
| Dec 2014 | $1.70 M(-31.5%) | $1.70 M(+23.4%) |
| Sept 2014 | - | $1.38 M(-35.7%) |
| June 2014 | - | $2.15 M(+10.8%) |
| Mar 2014 | - | $1.94 M(-22.1%) |
| Dec 2013 | $2.49 M(+51.8%) | $2.49 M(+55.1%) |
| Sept 2013 | - | $1.60 M(+7.4%) |
| June 2013 | - | $1.49 M(+1.7%) |
| Mar 2013 | - | $1.47 M(-10.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | $1.64 M(-26.0%) | $1.64 M(+13.6%) |
| Sept 2012 | - | $1.44 M(-19.0%) |
| June 2012 | - | $1.78 M(-16.6%) |
| Mar 2012 | - | $2.13 M(-3.6%) |
| Dec 2011 | $2.21 M(+25.1%) | $2.21 M(+171.8%) |
| Sept 2011 | - | $815.00 K(+3.7%) |
| June 2011 | - | $786.00 K(-8.4%) |
| Mar 2011 | - | $858.00 K(-51.6%) |
| Dec 2010 | $1.77 M(+68.3%) | $1.77 M(+129.7%) |
| Sept 2010 | - | $771.00 K(-25.6%) |
| June 2010 | - | $1.04 M(+16.9%) |
| Mar 2010 | - | $886.00 K(-15.8%) |
| Dec 2009 | $1.05 M(-2.5%) | $1.05 M(-1.4%) |
| Sept 2009 | - | $1.07 M(-21.3%) |
| June 2009 | - | $1.35 M(+2.8%) |
| Mar 2009 | - | $1.32 M(+22.2%) |
| Dec 2008 | $1.08 M(-58.5%) | $1.08 M(+52.4%) |
| Sept 2008 | - | $708.00 K(+5.0%) |
| June 2008 | - | $674.00 K(-31.5%) |
| Mar 2008 | - | $984.00 K(-62.2%) |
| Dec 2007 | $2.60 M(-56.6%) | $2.60 M(+98.3%) |
| Sept 2007 | - | $1.31 M(-6.4%) |
| June 2007 | - | $1.40 M(-18.4%) |
| Mar 2007 | - | $1.72 M(-71.3%) |
| Dec 2006 | $5.99 M(+334.0%) | $5.99 M(-5.6%) |
| Sept 2006 | - | $6.35 M(-10.1%) |
| June 2006 | - | $7.06 M(+16.5%) |
| Mar 2006 | - | $6.06 M(+339.1%) |
| Dec 2005 | $1.38 M(+37.3%) | $1.38 M(+12.7%) |
| Sept 2005 | - | $1.22 M(+38.6%) |
| June 2005 | - | $883.00 K(+7.3%) |
| Mar 2005 | - | $823.00 K(-18.1%) |
| Dec 2004 | $1.00 M(+165.9%) | $1.00 M(+65.6%) |
| Sept 2004 | - | $607.00 K(-13.0%) |
| June 2004 | - | $698.00 K(-38.4%) |
| Mar 2004 | - | $1.13 M(+199.5%) |
| Dec 2003 | $378.00 K(-43.3%) | $378.00 K(-5.7%) |
| Sept 2003 | - | $400.90 K(-4.0%) |
| June 2003 | - | $417.70 K(+33.8%) |
| Mar 2003 | - | $312.20 K(-53.2%) |
| Dec 2002 | $666.80 K(+21.1%) | $666.80 K(+54.4%) |
| Sept 2002 | - | $431.90 K(-39.6%) |
| June 2002 | - | $715.50 K(-8.3%) |
| Mar 2002 | - | $780.50 K(+41.7%) |
| Dec 2001 | $550.70 K | $550.70 K(+12.4%) |
| Sept 2001 | - | $490.00 K(+56.3%) |
| June 2001 | - | $313.50 K |
FAQ
- What is Galectin Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Galectin Therapeutics?
- What is Galectin Therapeutics annual current liabilities year-on-year change?
- What is Galectin Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Galectin Therapeutics?
- What is Galectin Therapeutics quarterly current liabilities year-on-year change?
What is Galectin Therapeutics annual total current liabilities?
The current annual current liabilities of GALT is $15.68 M
What is the all time high annual current liabilities for Galectin Therapeutics?
Galectin Therapeutics all-time high annual total current liabilities is $15.68 M
What is Galectin Therapeutics annual current liabilities year-on-year change?
Over the past year, GALT annual total current liabilities has changed by +$2.66 M (+20.47%)
What is Galectin Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of GALT is $25.26 M
What is the all time high quarterly current liabilities for Galectin Therapeutics?
Galectin Therapeutics all-time high quarterly total current liabilities is $25.26 M
What is Galectin Therapeutics quarterly current liabilities year-on-year change?
Over the past year, GALT quarterly total current liabilities has changed by +$14.74 M (+140.05%)